1. Home
  2. Browse Decisions
  3. F.Supp.2d
  4. 906 F.Supp.2d
  5. 906 F.Supp.2d 9 (2012)
 

GENZYME CORP. v. SHIRE HUMAN GENETIC THERAPIES

Civil Action No. 12-11386-RGS.

906 F.Supp.2d 9 (2012)

GENZYME CORP. v. SHIRE HUMAN GENETIC THERAPIES, INC., and Shire plc.

United States District Court, D. Massachusetts.

November 29, 2012.

Attorney(s) appearing for the Case

Melissa C. Allison , Scott P. Lewis , Anderson & Kreiger LLP, Cambridge, MA, Steven P. Hollman , Laura E. Schabinger , Hogan Lovells U.S. LLP, Washington, DC, for Plaintiff.

Jeffrey S. Bucholtz , Paul A. Mezzina , King & Spalding LLP, Washington, DC, Fred A. Kelly, Jr. , Nixon Peabody, LLP, Boston, MA, Kathleen E. McCarthy , King & Spalding, New York, NY, for Defendant.

MEMORANDUM AND ORDER ON DEFENDANTS' MOTIONS TO DISMISS

STEARNS, District Judge.

Plaintiff Genzyme Corp. alleges in a Verified Complaint (VC) that defendants Shire Human Genetic Therapies, Inc. (Shire HGT), and Shire plc, violated the Lanham Act, 15 U.S.C. § 1125 et seq., by publishing and distributing a press release falsely advertising the superior qualities of Shire's Gaucher disease treatment drug VPRIV over those of Genzyme's competing brand, Cerezyme...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases